Phase 1 Dyslipidemias Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
HypercholesterolaemiaMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG90 enrolled18 locationsNCT07491172
Recruiting
Phase 1Phase 2
Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome
Diabetes MellitusObesityMetabolic Syndrome+1 more
Chang Gung Memorial Hospital200 enrolled1 locationNCT06703788
Recruiting
Phase 1
To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults
Type 2 DiabetesDyslipidemias
Hyundai Pharm56 enrolled1 locationNCT06578676
Recruiting
Phase 1
A Safety and Tolerability Study Evaluating CTX310 in Subjects With Refractory Dyslipidemias
Refractory Dyslipidemias
CRISPR Therapeutics AG24 enrolled1 locationACTRN12623000809639